CIK: 1394923 - Address: C/O Bausch + Lomb Corporation, 520 Applewood Crescent, Vaughan, A6 L4K 4B4
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/9/23 18:18
6/7/23
BSIGBrightsphere Investment Group Inc.DEFinancInvAdvInvestment AdvicePaulson JohnMADTM.d00.0008New8D
6/26/20 17:46
6/24/20
BSIGBrightsphere Investment Group Inc.DEFinancInvAdvInvestment AdvicePaulson JohnNYDTP6,3379.790647320,001I
6/26/20 17:46
6/24/20
BSIGBrightsphere Investment Group Inc.DEFinancInvAdvInvestment AdvicePaulson JohnNYDTS-6,3379.790-647-320,001I
5/14/20 18:25
5/12/20
BHCBausch Health Companies Inc.NJHealthDrugPharmaceutical PreparationsPaulson JohnNYDP.m83,25216.6505,0002425,839I
2/27/19 17:02
2/25/19
BSIGBrightsphere Investment Group PlcX0FinancInvAdvInvestment AdvicePaulson JohnNYDTP206,32113.95014,79028420,001I
3/8/18 17:04
3/6/18
VRXValeant Pharmaceuticals International, Inc.NJHealthDrugPharmaceutical PreparationsPaulson JohnNYDS-108,82615.400-7,067-2520,839I
3/8/18 17:04
3/6/18
VRXValeant Pharmaceuticals International, Inc.NJHealthDrugPharmaceutical PreparationsPaulson JohnNYDP108,82615.4007,0675120,839I
11/20/17 18:00
11/16/17
VRXValeant Pharmaceuticals International, Inc.NJHealthDrugPharmaceutical PreparationsPaulson JohnNYDP4,95614.400344220,839I
11/20/17 18:00
11/16/17
VRXValeant Pharmaceuticals International, Inc.NJHealthDrugPharmaceutical PreparationsPaulson JohnNYDS-4,95314.390-344-220,839I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact